Nuvalent Valuation
| NUVL Stock | USD 92.73 1.56 1.71% |
At this time, the firm appears to be overvalued. Nuvalent secures a last-minute Real Value of $82.23 per share. The latest price of the firm is $92.73. Our model forecasts the value of Nuvalent from analyzing the firm fundamentals such as Shares Owned By Insiders of 2.83 %, return on equity of -0.3, and Current Valuation of 5.3 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Nuvalent's valuation include:
Price Book 5.771 | Enterprise Value 5.3 B | Enterprise Value Ebitda (22.26) |
Overvalued
Today
Please note that Nuvalent's price fluctuation is very steady at this time. Calculation of the real value of Nuvalent is based on 3 months time horizon. Increasing Nuvalent's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nuvalent stock is determined by what a typical buyer is willing to pay for full or partial control of Nuvalent. Since Nuvalent is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nuvalent Stock. However, Nuvalent's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 92.73 | Real 82.23 | Target 75.43 | Hype 92.99 | Naive 90.15 |
The intrinsic value of Nuvalent's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Nuvalent's stock price.
Estimating the potential upside or downside of Nuvalent helps investors to forecast how Nuvalent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nuvalent more accurately as focusing exclusively on Nuvalent's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Nuvalent's intrinsic value based on its ongoing forecasts of Nuvalent's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Nuvalent's closest peers.
Nuvalent Cash |
|
Nuvalent Valuation Trend
Knowing Nuvalent's actual value is paramount for traders when making sound investment determinations. Using both Nuvalent's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Nuvalent Total Value Analysis
Nuvalent is now anticipated to have valuation of 5.3 B with market capitalization of 6.48 B, debt of 31.82 M, and cash on hands of 256.96 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nuvalent fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.3 B | 6.48 B | 31.82 M | 256.96 M |
Nuvalent Asset Utilization
One of the ways to look at asset utilization of Nuvalent is to check how much profit was generated for every dollar of assets it reports. Nuvalent secures a negative usage of assets of -0.19 %, losing $0.001863 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Nuvalent shows how discouraging it operates for each dollar spent on its assets.Nuvalent Ownership Allocation
The majority of Nuvalent outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Nuvalent to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Nuvalent. Please pay attention to any change in the institutional holdings of Nuvalent as this could imply that something significant has changed or is about to change at the company.Nuvalent Profitability Analysis
Net Loss for the year was (126.22 M) with profit before overhead, payroll, taxes, and interest of 0.About Nuvalent Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Nuvalent. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nuvalent based exclusively on its fundamental and basic technical indicators. By analyzing Nuvalent's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Nuvalent's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nuvalent. We calculate exposure to Nuvalent's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nuvalent's related companies.Nuvalent Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nuvalent does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 58.2 M |
Nuvalent Current Valuation Indicators
Nuvalent's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Nuvalent's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Nuvalent, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Nuvalent's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Nuvalent's worth.When determining whether Nuvalent is a strong investment it is important to analyze Nuvalent's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuvalent's future performance. For an informed investment choice regarding Nuvalent Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.49) | Return On Assets (0.19) | Return On Equity (0.30) |
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.